[1]
2025. Study on the mechanism of hyperoside in affecting the biological progression and radiosensitivity of esophageal carcinoma by modulating the STAT3/AKT/ERK pathway. Biomolecules and Biomedicine. 25, 5 (Apr. 2025), 1150–1161. DOI:https://doi.org/10.17305/bb.2024.11201.